Related Experiment Video
Updated: Jun 12, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Managing the adolescent athlete with type 1 diabetes mellitus
1Michigan State University College of Human Medicine, Kalamazoo, MI 49008, USA. draznin@kcms.msu.edu
Pediatric Clinics of North America
|June 12, 2010
Summary
Managing diabetes in adolescent athletes requires understanding the athlete, their sport, and the interplay between exercise and diabetes. This article provides resources for effective diabetes care in young athletes.
Area of Science:
- Sports Medicine
- Endocrinology
- Pediatrics
Background:
- Adolescent athletes with diabetes require specialized management strategies.
- Effective diabetes care in this population is crucial for both athletic performance and overall health.
- Current resources for guiding this care are often fragmented.
Purpose of the Study:
- To provide a comprehensive overview of essential knowledge for managing diabetes in adolescent athletes.
- To identify and highlight key resources for healthcare providers, athletes, and support systems.
- To facilitate informed decision-making for safe and successful diabetes management during athletic participation.
Main Methods:
- Literature review of existing guidelines and research on diabetes and exercise.
- Identification of reliable information sources for athlete-specific needs.
- Case illustration examples (not detailed in abstract, but implied by 'illustrates the use of some of them')
Main Results:
- Key areas for knowledge acquisition include athlete specifics, sport demands, exercise physiology in diabetes, and available support networks.
- Several valuable resources are identified, offering practical guidance.
- The article demonstrates how to apply these resources for tailored recommendations.
Conclusions:
- Successful diabetes management in adolescent athletes is achievable with adequate knowledge and resource utilization.
- A multidisciplinary approach involving healthcare providers, coaches, and families is beneficial.
- This article serves as a guide to navigate the complexities of supporting these athletes.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...